Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04800211 · ClinicalTrials.gov registry record · NA
Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products
A NA study, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT04800211 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 450 participants.
The verdict
NCT04800211, a NA study, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
The purpose of this study was to estimate changes in biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in adult cigarette smokers (AS) who switched to using an e-vapor product (EVP) relative to adult smokers who continue smoking exclusively.
Interventions
- OTHER Experimental: Test Product 1
- OTHER Experimental: Test Product 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2017-01-17 |
| Est. Completion | 2018-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04800211
The ClinicalTrials.gov registry entry for NCT04800211 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Experimental: Test Product 1 is the first listed.
NCT04800211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04800211 about?
NCT04800211 is a clinical study titled "Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Completely Switch to E-vapor Products". The purpose of this study was to estimate changes in biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in adult cigarette smokers (AS) who switched to using an e-vapor product (EVP) relative to adult smokers who continue smoking exclusively.
What is the current status of trial NCT04800211?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2017-01-17. Estimated completion is 2018-11-06.
What interventions are being tested in trial NCT04800211?
The interventions under investigation include: Experimental: Test Product 1 (OTHER), Experimental: Test Product 2 (OTHER).
Who is sponsoring clinical trial NCT04800211?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.